共 147 条
[1]
Burlina AP(2011)Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel BMC Neurol 11 61-812
[2]
Sims KB(2011)Two novel alpha-galactosidase a mutations causing fabry disease: a missense mutation M11V in a heterozygote woman and a nonsense mutation R190X in a hemizygote man Clin Biochem 44 809-577
[3]
Politei JM(2012)Fabry disease 'The New great Imposter’: results of the French observatoire in internal medicine departments (FIMeD) Clin Genet 81 571-192
[4]
Bennett GJ(2011)Fabry disease in an oligosymptomatic male Isr Med Assoc J 13 191-173
[5]
Baron R(2011)Update on role of agalsidase alfa in management of Fabry disease Drug Des Devel Ther 5 155-868
[6]
Sommer C(2010)Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease Stroke 41 863-82
[7]
Celtikci B(2011)Enzyme replacement therapy for Fabry disease: some answers but more questions Ther Clin Risk Manag 7 69-306
[8]
Topçu M(2010)Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy Neurol Sci 31 299-619
[9]
Ozkara HA(2011)Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies J Inherit Metab Dis 34 605-1796
[10]
Lidove O(2005)Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study Lancet 366 1794-775